Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.48 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 2/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | ADH1B | P00325 | 1/20 | 0.38 |
| ▸ | ADH1C | P00326 | 1/20 | 0.38 |
| ▸ | ADH1A | P07327 | 1/20 | 0.38 |
| ▸ | ADH4 | P08319 | 1/20 | 0.38 |
| ▸ | ADH7 | P40394 | 1/20 | 0.38 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.38 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.38 |
| ▸ | GMNN | O75496 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | THPO | P40225 | 1/20 | 0.38 |
| ▸ | MTOR | P42345 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8385121 | 1.00 | OPRM1 (0.48) | OPRM1SPHK1LMNATP53DNM1 | |
| SCHEMBL8385082 | 1.00 | OPRM1 (0.48) | OPRM1SPHK1LMNATP53DNM1 | |
| SCHEMBL331199 | 1.00 | OPRM1 (0.48) | OPRM1SPHK1LMNATP53DNM1 | |
| SCHEMBL924201 | 1.00 | OPRM1 (0.48) | OPRM1SPHK1LMNATP53DNM1 | |
| SCHEMBL8386214 | 1.00 | OPRM1 (0.48) | OPRM1SPHK1LMNATP53DNM1 | |
| SCHEMBL332857 | 1.00 | OPRM1 (0.48) | OPRM1SPHK1LMNATP53DNM1 | |
| SCHEMBL8383457 | 1.00 | OPRM1 (0.48) | OPRM1SPHK1LMNATP53DNM1 | |
| SCHEMBL17257510 | 1.00 | OPRM1 (0.48) | OPRM1SPHK1LMNATP53DNM1 | |
| SCHEMBL37786 | 1.00 | OPRM1 (0.48) | OPRM1SPHK1LMNATP53DNM1 | |
| SCHEMBL2266510 | 1.00 | OPRM1 (0.48) | OPRM1SPHK1LMNATP53DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 501 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250113829-A1 | HIGH MOLECULAR WEIGHT MODIFIED RNA COMPOSITIONS | nanoSUR LLC | 2025-04-10 | — | — | US | claimed |
| CN-118613517-A | Preparation and use of polyisocyanates containing iminooxadiazinedione groups | 巴斯夫欧洲公司 | 2024-09-06 | — | — | CN | claimed |
| WO-2024165361-A1 | PREPARATION OF POLYISOCYANATES CONTAINING IMINOOXADIAZINEDIONE GROUPS AND THEIR USE | BASF SE (DE) | 2024-08-15 | — | — | WO | claimed |
| EP-3350143-B1 | PROCESS FOR DEACTIVATION OF AN OLEFIN OLIGOMERIZATION CATALYST | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2024-05-15 | — | — | EP | claimed |
| WO-2023138938-A1 | PREPARATION OF POLYISOCYANATES CONTAINING IMINOOXADIAZINEDIONE GROUPS AND THEIR USE | BASF SE (DE) | 2023-07-27 | — | — | WO | claimed |
| CN-116087496-A | Polysaccharide antigen-antibody immune complex dissociating agent | 郑州安图生物工程股份有限公司 | 2023-05-09 | — | — | CN | claimed |
| EP-2847246-B1 | PREPARATION OF POLYISOCYANATES HAVING ISOCYANURATE GROUPS AND THEIR USE | BASF SE (DE) | 2016-04-20 | — | — | EP | claimed |
| EP-2847246-A1 | PREPARATION OF POLYISOCYANATES HAVING ISOCYANURATE GROUPS AND THEIR USE | BASF SE (DE) | 2015-03-18 | — | — | EP | claimed |
| EP-1669383-B1 | CATALYST COMPOSITION FOR PRODUCTION OF RIGID POLYURETHANE FOAM AND ISOCYANURATE-MODIFIED RIGID POLYURETHANE FOAM AND RAW-MATERIAL COMPOSITION CONTAINING THE SAME | TOSOH CORP (JP) | 2014-11-12 | — | — | EP | claimed |
| US-8742166-B2 | Preparation of polyisocyanates having isocyanurate groups and their use | BASF SE (DE) | 2014-06-03 | — | — | US | claimed |
| EP-0477198-B1 | METHOD FOR RECOVERING RECOMBINANT PROTEINS | PITMAN MOORE INC (US) | 1993-11-03 | — | — | EP | claimed |
| US-5149876-A | Bealting an olefin with carbon monoxide hydrogen and primary and/or secondary amines in presence of rhodium-arylphospine salt complex | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-09-22 | — | — | US | claimed |
| EP-0302375-B1 | PROCESS FOR THE PREPARATION OF ALDEHYDES | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-04-15 | — | — | EP | claimed |
| WO-1991013122-A1 | SUBSTITUTED XANTHENE COMPOUNDS | STEADFAST, INCORPORATED (US) | 1991-09-05 | — | — | WO | claimed |
| EP-0151114-B1 | ACID BASED VARIABLE VISCOSITY COMPOSITIONS SUCH AS CORROSION AND GREASE REMOVERS AND POLISHERS | Lott, Peter F., Dr. (US) | 1990-04-04 | — | — | EP | claimed |
| US-4879418-A | HYDROFORMYLATION, RHODIUM CATALYST, WATER SOLUBLE PHOSPHINE | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-11-07 | — | — | US | claimed |
| EP-0109223-B1 | ELECTROLYTE FOR ZINC-BROMINE STORAGE BATTERIES | KABUSHIKI KAISHA MEIDENSHA MEIDENSHA ELECTRIC MFG. CO., LTD. (JP) | 1987-07-22 | — | — | EP | claimed |
| EP-0185240-A2 | Process for the preparation of N-substituted benz[c,d]indol-2-ones | BAYER AG (DE) | 1986-06-25 | — | — | EP | claimed |
| US-4225498-A | Preparation of N-substituted oligo-imides | RHONE-POULENC INDUSTRIES (FR) | 1980-09-30 | — | — | US | claimed |
| US-4001308-A | REACTION OF DIBROMO COMPOUND WITH METAL SALT OF ACETIC ACID | TEIJIN LIMITED (JA) | 1977-01-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250113829-A1 | HIGH MOLECULAR WEIGHT MODIFIED RNA COMPOSITIONS | NSUN2, NSUN3, RNGTT | OPRM1 1944/4885SPHK1 2690/4885LMNA 606/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.